Skip to content
value.today
Surrozen, Inc. logo

Surrozen, Inc.

SRZN
$562 Mmarket cap on Oct 30, 2026+2574.1% since Jan 2024
Compare
World rank
#12,067
Revenue
$3 M
For year ending December-2025
Net income
$-242 M
-6954.9% margin
SEC filing
Employees
44
As of March 1, 2026
SEC filing

Surrozen, Inc. in brief

Surrozen, Inc. is a listed company in the Biotechnology industry, based in South San Francisco, California, USA. Its market value was $562 M on 30 October 2026, which makes it the 12,067th largest listed company in the world and the 2,457th largest in the USA on this site. In the year to December 2025 it had sales of $3 M and a net loss of $242 M. It employs about 44 people and Craig C. Parker is its chief executive. Its largest product and service lines by sales in 2025 were Research service revenue (101%). Its shares trade under the symbol SRZN (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Surrozen, Inc.

We are a biotechnology company committed to discovering and developing product candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair. Our current strategic focus is ophthalmology, where Wnt signaling plays a central role in retinal vascular integrity, barrier function, and tissue maintenance. We are located in South San Francisco, California.

Our mission is to transform the treatment of serious ophthalmic disease by fully exploiting the Wnt pathway. Building upon the seminal work of our founders and scientific advisors who discovered the Wnt gene and key regulators of the Wnt pathway, we have made breakthrough discoveries that we believe will overcome previous limitations in harnessing the potential of Wnt biology in a tissue-selective manner. These breakthroughs enable us to rapidly and flexibly design tissue-targeted therapeutics that modulate Wnt signaling and form the foundation of our ophthalmology portfolio and research programs, which are designed to restore tissue structure and function in serious eye diseases with high unmet medical need.

From the company's annual report filed with the US SEC: read the report

Surrozen, Inc. timeline

2 events, 2020–2021
  1. 2020
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2021
  4. ✎
    Renamed Surrozen, Inc./DE
    Formerly Consonance-HFW Acquisition Corp..

Events of Surrozen, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$152 M$303 M$455 M$606 M2023202420252026

World rank over time

▲ up 7,120 places since 2022
2022-01-07: #19211#19,21120222022-12-25: #29578#29,57820222023-07-30: #28714#28,71420232024-01-05: #28741#28,74120242026-03-08: #8770#8,77020262026-08-01: #14419#14,41920262026-10-14: #13137#13,13720262026-10-30: #12091#12,0912026

Rank in USA: #3,888 (Jan 2022) · #5,304 (Dec 2022) · #5,109 (Jul 2023) · #4,351 (Jan 2024) · #1,642 (Mar 2026) · #2,914 (Aug 2026) · #2,592 (Oct 2026) · #2,460 (Oct 2026)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
161.4×
Price / book
—
Free cash flow yield
-5.4%
Net margin
-6954.9%
Operating margin
-1209.5%
Return on equity
—
Liabilities / assets
290.2%
Revenue growth
-67.4%
R&D / revenue
843.7%
Revenue per employee
$79 K
Profit per employee
$-5.5 M

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue —, net income $-33M—FY20Fiscal year ending Dec 2021: revenue —, net income $-55M—FY21Fiscal year ending Dec 2022: revenue $13M, net income $-36M$13MFY22Fiscal year ending Dec 2023: revenue —, net income $-43M—FY23Fiscal year ending Dec 2024: revenue $11M, net income $-64M$11MFY24Fiscal year ending Dec 2025: revenue $3M, net income $-242M$3MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$3M-67.4%$-42M$-242M-6954.9%
Dec 2024$11M—$-26M$-64M-596.2%
Dec 2023——$-46M$-43M—
Dec 2022$13M—$-44M$-36M-288.0%
Dec 2021——$-54M$-55M—
Dec 2020——$-33M$-33M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-30M$0M$-30M$-32.37—
Dec 2024$-18M$0M$-18M$-21.67—
Dec 2023$-40M$0M$-41M$-21.33—
Dec 2022$-44M$1M$-45M$-15.56—
Dec 2021$-49M$1M$-50M$-2.21—
Dec 2020$-29M$1M$-30M——

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue —, net income $-28M—Dec ’24Three months to Mar 2025: revenue $1M, net income $-27M$1MMar ’25Three months to Jun 2025: revenue $1M, net income $40M$1MJun ’25Three months to Sep 2025: revenue $1M, net income $-72M$1MSep ’25Three months to Dec 2025 (from the annual report): revenue $1M, net income $-183M$1MDec ’25Three months to Mar 2026: revenue $5M, net income $-128M$5MMar ’26Three months to Jun 2026: revenue $5M, net income $50M$5MJun ’26Three months to Sep 2026: revenue —, net income $-130M—Sep ’26

Latest quarter to Sep 2026: revenue —, net income $-130M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Surrozen, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$3 M
Operating income
$-42 M
Net income
$-242 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$99 M
Total liabilities
$286 M
Total equity
$-188 M

As of December-2025

Top 90 institutional investors in Surrozen, Inc.#

As of Sep 30, 2026
90 institutions held 15.7 M shares (about 82.3% of the shares outstanding) on Sep 30, 2026. The ten largest hold 49.0%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Surrozen, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Column Group LLC2,951,433New15.48%$95 MNov 16, 2026
2Boxer Capital Management, LLC1,360,683+255,000 (+23.06%)7.14%$44 MNov 16, 2026
3Commodore Capital LP885,000New4.64%$28 MNov 16, 2026
4Point72 Asset Management, L.P.806,407+142,135 (+21.40%)4.23%$26 MNov 16, 2026
5Venrock Adviser, LLC632,9310 (0.00%)3.32%$20 MNov 16, 2026
6Balyasny Asset Management L.P.626,170+421,138 (+205.40%)3.29%$20 MNov 16, 2026
7Millennium Management LLC596,130-86,949 (-12.73%)3.13%$19 MNov 16, 2026
8Samlyn Capital, LLC504,482New2.65%$16 MNov 16, 2026
9BlackRock, Inc.498,824+103,960 (+26.33%)2.62%$16 MNov 13, 2026
10Kynam Capital Management, LP486,252New2.55%$16 MNov 16, 2026
11Perceptive Advisors LLC439,685-64,300 (-12.76%)2.31%$14 MNov 16, 2026
12Spruce Street Capital LP432,0400 (0.00%)2.27%$14 MNov 13, 2026
13Stempoint Capital LP418,527-184,271 (-30.57%)2.20%$13 MNov 16, 2026
14RTW Investments, LP393,560New2.06%$13 MNov 16, 2026
15Adage Capital Partners GP, L.L.C.388,653+300,000 (+338.40%)2.04%$13 MNov 16, 2026
16Vanguard Capital Management LLC370,128-22,422 (-5.71%)1.94%$12 MNov 13, 2026
17Braidwell LP335,206-55,547 (-14.22%)1.76%$11 MNov 16, 2026
18Two Sigma Investments, LP326,345+255,226 (+358.87%)1.71%$11 MNov 16, 2026
19Integral Health Asset Management, LLC325,000New1.71%$10 MNov 16, 2026
20Kalehua Capital Management LLC286,092-484,264 (-62.86%)1.50%$9 MNov 13, 2026
21Vivo Capital, LLC260,0000 (0.00%)1.36%$8 MNov 13, 2026
22UBS Group AG257,103+227,874 (+779.62%)1.35%$8 MNov 10, 2026
23Geode Capital Management, LLC194,838-6,814 (-3.38%)1.02%$6 MNov 6, 2026
24Fred Alger Management, LLC176,878+152,874 (+636.87%)0.93%$6 MNov 16, 2026
25Janus Henderson Group Ltd.167,084—0.88%$5 MNov 16, 2026
Show all 90: investors 26 to 90
Institutional investors 26 to 90 in Surrozen, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Acuta Capital Partners, LLC152,541-20,854 (-12.03%)0.80%$5 MNov 16, 2026
27State Street Corp136,319+3,235 (+2.43%)0.72%$4 MNov 12, 2026
28Regents Of The University Of California133,2070 (0.00%)0.70%$4 MOct 26, 2026
29Goldman Sachs Group Inc112,697-834 (-0.73%)0.59%$4 MNov 16, 2026
30Euclidean Capital LLC87,6960 (0.00%)0.46%$3 MNov 16, 2026
31Northern Trust Corp63,414-195 (-0.31%)0.33%$2 MNov 16, 2026
32Renaissance Technologies LLC63,136+50,762 (+410.23%)0.33%$2 MNov 12, 2026
33Jump Financial, LLC61,084New0.32%$2 MNov 13, 2026
34Vanguard Fiduciary Trust Co56,226-3,349 (-5.62%)0.29%$2 MNov 13, 2026
35ArrowMark Colorado Holdings LLC55,1230 (0.00%)0.29%$2 MNov 16, 2026
36AQR Capital Management LLC52,670New0.28%$2 MNov 16, 2026
37Vanguard Portfolio Management LLC51,926+900 (+1.76%)0.27%$2 MNov 13, 2026
38Stonepine Capital Management, LLC44,100New0.23%$1 MNov 13, 2026
39BNP Paribas Financial Markets40,852+32,823 (+408.81%)0.21%$1 MNov 12, 2026
40Trexquant Investment LP39,345New0.21%$1 MNov 16, 2026
41Citadel Advisors LLC35,571New0.19%$1 MNov 16, 2026
42Man Group plc35,515New0.19%$1 MNov 16, 2026
43Longaeva Partners L.P.32,941New0.17%$1 MNov 16, 2026
44Price T Rowe Associates Inc /MD/27,7410 (0.00%)0.15%$1 MNov 16, 2026
45Jane Street Group, LLC25,332New0.13%$1 MNov 12, 2026
46Squarepoint Ops LLC22,262New0.12%$1 MNov 9, 2026
47Informed Momentum Co LLC21,139New0.11%$1 MNov 16, 2026
48Lynx1 Capital Management LP20,000New0.10%$1 MNov 16, 2026
49Sphera Funds Management LTD.18,821New0.10%$1 MNov 16, 2026
50Charles Schwab Investment Management Inc18,022+1,725 (+10.58%)0.09%$1 MNov 16, 2026
51Bank of New York Mellon Corp17,119+1,740 (+11.31%)0.09%$1 MNov 5, 2026
52Algert Global LLC16,430New0.09%$1 MNov 17, 2026
53LMR Partners LLP13,5570 (0.00%)0.07%$0 MNov 16, 2026
54Nuveen, LLC12,907+3,127 (+31.97%)0.07%$0 MNov 10, 2026
55SEI Investments Co12,766New0.07%$0 MNov 10, 2026
56Jain Global LLC9,462New0.05%$0 MNov 16, 2026
57Quadrature Capital Ltd9,007New0.05%$0 MNov 13, 2026
58Rhumbline Advisers8,504+374 (+4.60%)0.04%$0 MNov 10, 2026
59XTX Topco Ltd7,590-9,238 (-54.90%)0.04%$0 MNov 16, 2026
60Bank Of America Corp /de/7,406-23,889 (-76.33%)0.04%$0 MNov 16, 2026
61Deutsche Bank AG\6,431-871 (-11.93%)0.03%$0 MNov 6, 2026
62China Universal Asset Management Co., Ltd.5,000+1,350 (+36.99%)0.03%$0 MOct 28, 2026
63New York State Common Retirement Fund4,1000 (0.00%)0.02%$0 MNov 17, 2026
64Morgan Stanley3,911-3,240 (-45.31%)0.02%$0 MNov 13, 2026
65Jpmorgan Chase & Co3,613+569 (+18.69%)0.02%$0 MNov 12, 2026
66MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,582+201 (+5.94%)0.02%$0 MNov 16, 2026
67Barclays PLC2,863+1,096 (+62.03%)0.01%$0 MNov 6, 2026
68Royal Bank Of Canada2,711+2,400 (+771.70%)0.01%$0 MNov 16, 2026
69Vanguard Global Advisers, LLC2,604+34 (+1.32%)0.01%$0 MNov 13, 2026
70Wells Fargo & Company/mn2,256-4,442 (-66.32%)0.01%$0 MNov 16, 2026
71Police & Firemen's Retirement System of New Jersey2,1660 (0.00%)0.01%$0 MNov 9, 2026
72Global Retirement Partners, LLC1,393New0.01%$0 MNov 10, 2026
73Tower Research Capital LLC (TRC)1,377+949 (+221.73%)0.01%$0 MNov 16, 2026
74Strs Ohio1,000-400 (-28.57%)0.01%$0 MOct 30, 2026
75Russell Investments Group, Ltd.802+215 (+36.63%)0.00%$0 MNov 6, 2026
76FMR LLC792+444 (+127.59%)0.00%$0 MNov 10, 2026
77Legal & General Group Plc7150 (0.00%)0.00%$0 MNov 16, 2026
78Ameritas Investment Partners, Inc.6660 (0.00%)0.00%$0 MNov 13, 2026
79Citigroup Inc632-2,823 (-81.71%)0.00%$0 MNov 4, 2026
80Caitong International Asset Management Co., Ltd526+525 (+52500.00%)0.00%$0 MOct 29, 2026
81Quarry LP399New0.00%$0 MNov 16, 2026
82Sterling Capital Management LLC241+215 (+826.92%)0.00%$0 MOct 22, 2026
83Arax Advisory Partners138New0.00%$0 MNov 12, 2026
84Allworth Financial LP137New0.00%$0 MNov 17, 2026
85California State Teachers Retirement System1010 (0.00%)0.00%$0 MNov 13, 2026
86GAMMA Investing LLC62New0.00%$0 MOct 8, 2026
87SJS Investment Consulting Inc.52New0.00%$0 MOct 26, 2026
88PNC Financial Services Group, Inc.17New0.00%$0 MNov 6, 2026
89US Bancorp \de\14New0.00%$0 MNov 5, 2026
90SBI Securities Co., Ltd.5New0.00%$0 MOct 22, 2026

Mutual funds holding Surrozen, Inc.#

48 funds hold shares worth $22 M (about 6.9% of the company). Since their previous reports 43 added shares and 1 sold, buying $16 M net.
Mutual funds holding Surrozen, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.282,365$7 M2.2%<0.01%+189%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors161,295$4 M1.3%<0.01%newJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.102,939$3 M0.81%<0.01%+60%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC80,268$2 M0.63%<0.01%newJul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors62,426$2 M0.49%0.01%newJun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC26,513$1 M0.21%<0.01%−0.8%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors23,661$1 M0.19%0.04%+93%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.18,022$0 M0.14%<0.01%newJul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC12,411$0 M0.10%<0.01%newJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC11,836$0 M0.09%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC8,584$0 M0.07%<0.01%+5.6%May 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC9,780$0 M0.08%<0.01%newJul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC7,084$0 M0.06%<0.01%newJun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC6,869$0 M0.05%0.01%newJun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC6,143$0 M0.05%<0.01%+49%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation5,500$0 M0.04%<0.01%newJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.3,790$0 M0.03%<0.01%newJun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.3,751$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.3,500$0 M0.03%<0.01%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.3,495$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC3,522$0 M0.03%<0.01%newJul 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC2,740$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC2,663$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC1,860$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC1,669$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC1,575$0 M0.01%0.02%+75%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS1,474$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC1,611$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,270$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC1,270$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 Tiff Multi-Asset FundTIFF Advisory Services, LLC1,231$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.1,149$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.1,108$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC990$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC947$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC881$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC860$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management666$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC599$0 M<0.01%0.01%newJun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC584$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC587$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.644$0 M<0.01%<0.01%+130%Jul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS638$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC561$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC364$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC225$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC198$0 M<0.01%<0.01%+13%Jun 30, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.185$0 M<0.01%<0.01%newJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 48 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Surrozen, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$6.9 M
52 purchases, 6 insiders
Sold, 12 months
$7.2 M
7 sales, 4 insiders
Net, 12 months
-$356 K
open market only
Insiders on file
23
since
$12.0 M-$6.9 M$0Apr 2024: bought $3.0 M (6 trades), sold $0 (0 trades)Apr 24Jan 2025: bought $0 (0 trades), sold $35 K (2 trades)Mar 2025: bought $12.0 M (3 trades), sold $0 (0 trades)MarNov 2025: bought $4.0 M (4 trades), sold $0 (0 trades)Dec 2025: bought $695 K (8 trades), sold $0 (0 trades)DecJan 2026: bought $1.4 M (26 trades), sold $53 K (2 trades)Feb 2026: bought $556 K (8 trades), sold $0 (0 trades)FebMar 2026: bought $4.2 M (10 trades), sold $0 (0 trades)May 2026: bought $0 (0 trades), sold $271 K (3 trades)MayJul 2026: bought $0 (0 trades), sold $6.9 M (2 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Surrozen, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Column Group III GP, LP10% ownerExercise of in-the-money derivativeindirect+485,830$11.60$5.6 M1.39 MForm 4
filed Tim KutzkeyDirector, 10% ownerExercise of in-the-money derivativeindirect+485,830$11.60$5.6 M1.39 MForm 4
filed Tim KutzkeyDirector, 10% ownerExercise of in-the-money derivativeindirect+548,653$11.60$6.4 M1.57 MForm 4
filed Column Group III GP, LP10% ownerExercise of in-the-money derivativeindirect+548,653$11.60$6.4 M1.57 MForm 4
filed Tim KutzkeyDirector, 10% ownerExercise of in-the-money derivativeindirect+517,241$11.60$6.0 M862,068Form 4
filed Column Group III GP, LP10% ownerExercise of in-the-money derivativeindirect+517,241$11.60$6.0 M862,068Form 4
filed Chen-Ming Yu10% ownerSellindirect-162,500$21.25$3.5 M574,054Form 4
filed Chen-Ming Yu10% ownerSellindirect-162,500$21.25$3.5 M574,047Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Surrozen, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
3.2 M
33.1% of shares · 8.51 days to cover
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-5.69 reverse split in the period to ; 1-for-5.69 reverse split

Fails to deliver

  • : 996 shares at $29.46
  • : 494 shares at $30.35
  • : 2 shares at $29.53
  • : 4,981 shares at $25.48
  • : 1,894 shares at $25.75

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Surrozen, Inc. scorecard#

Passes 1 of the 14 checks that could be worked out: strongest in financial health (1 of 3), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation0 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
    • ✗Price to sales below its peers' median161.4×Price to sales 161.4× against Biotechnology's median of 8.7×.
    • ✗Free cash flow yield above 5%-5.4%Free cash flow is -5.4% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth0 of 3
    • ✗Revenue grew in the newest year-67.3%Revenue down 67.3% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-32.37 vs -21.67Diluted EPS -32.37 in fiscal 2025 against -21.67 the year before (report's currency).
    • ✗Net income higher than five years earlier-$242 M-$242 M in fiscal 2025 against -$33 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 2
    • ✗Profitable in the newest year-$242 MNet income -$242 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 3
    • ✓Short-term assets cover short-term liabilities9.2×Current ratio 9.22 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-6.68Z-score -6.68 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year133.3%Diluted shares up 133.3% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Surrozen, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Surrozen, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue3.5110130—
Research and development292127374026
General and administrative16151620147.1
Operating expenses463646575433
Operating income−42−26−46−44−54−33
Interest and finance income3.01.72.30.80.10.1
Other non-operating income (expense)−26−190.47.6−0.30
Income before tax−242−64————
Income tax000000
Net income including minority interests−242−64−43−36−55−33
Net income attributable to shareholders−242−64−43−36−55−33
Earnings per share, basic-32.37-21.67-21.33-15.56r-2.21—
Earnings per share, diluted-32.37-21.67-21.33-15.56r-2.21—
Shares, weighted average (basic)0.00.00.00.0r0.0—
Shares, weighted average (diluted)0.00.00.00.0r0.0r16
Balance sheet
Cash and cash equivalents893536253335r
Short-term investments——0516914
Receivables02.02.22.00—
Other current assets2.11.82.93.53.31.0
Current assets9239418110550r
Property, plant and equipment0.40.62.03.64.85.8
Right-of-use (leased) assets6.07.81.93.34.65.6
Long-term investments—————0
Total assets9948468913762r
Accounts payable0.70.30.50.72.71.8
Current liabilities9.97.37.19.7147.3r
Lease liabilities (non-current)5.36.60.93.45.67.5
Total liabilities286708.1132715r
Retained earnings−527−285−222−179−143−88r
Shareholders' equity−188−21387611047r
Total liabilities and equity9948468913762r
Shares outstanding9.83.32.12.0r35r18
Cash-flow statement
Depreciation and amortization0.51.41.92.02.11.9
Share-based compensation3.84.14.44.52.30.6
Cash from operating activities−30−18−40−44−49−29
Capital expenditure−0.1−0.0−0.4−0.7−1.3−0.9
Cash from investing activities−0.1−0.05238−78−15
Shares issued7516001240
Shares bought back——0−2.60—
Cash from financing activities85160.3−2.612550
Change in cash55−1.512−8.4−1.95.9
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Surrozen, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Research service revenue$4 M101%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at Surrozen, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$2.8 M
Craig Parker
Other top executives, average
$1.4 M
the CEO earned 2× this
$100 invested is now
$240
Surrozen, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Craig Parker$2.8 M$4.8 M$1.4 M$240
2024Craig Parker$1.5 M$1.9 M$927 K$153

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Surrozen, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 4 · Material agreement 4 · Agreement ended 1 · Unregistered share sale 3 · Shareholder vote 3 · Results announced 12

Surrozen, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Unregistered share saleResults announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officersResults announced8-K
Agreement ended8-K
Material agreement8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Material agreementUnregistered share sale8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of Surrozen, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$76 MPrivate placement after listing$50 to $250 million29equity, optionsSEC
Apr 2024$193 MPrivate placement after listing$50 to $250 million18equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Surrozen, Inc.#

1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $130 K a year.

Certified, FY2025
1
#1,986 among companies on value.today
Worker positions
1
Median wage offered
$130 K
a year, full-time
Applications filed
1
Surrozen, Inc.: most frequent H-1B job titles in fiscal 2025
Job titlePositionsMedian wage offered
Scientist II, Protein SciencesMedical Scientists, Except Epidemiologists1$130 K

Where: South San Francisco, CA 1

Surrozen, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202511$130 K1
FY202411$143 K1
FY202322$111 K2
FY202244$121 K4
FY202144$103 K4
FY202022$64 K2

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Surrozen, Inc.

Discuss Surrozen, Inc.#

2 automatic updates and 0 member comments. Sign in to comment and react.

  • Results announced on 9 November 2026automatic update · Nov 9, 2026

    Surrozen, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: a net loss of $130 million.

  • Mutual funds: 48 funds hold $22 millionautomatic update · Jul 31, 2026

    48 mutual funds in 1 country hold shares of Surrozen, Inc. worth $22 million, about 6.9% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 43 funds added shares and 1 sold; on balance they bought $16 million. Share splits are not counted as trading.

How Surrozen, Inc. compares in Biotechnology

  • Market cap$562 M · higher than 60% of 726
  • Revenue$3 M · higher than 33% of 647
  • Revenue growth-67.3% · higher than 12% of 438
  • Price / sales161.4× · lower than 7% of 339
  • FCF yield-5.4% · higher than 71% of 449

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Surrozen, Inc.🇺🇸$562 M——-67.3%
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of March 1, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Surrozen, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Surrozen, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Surrozen, Inc.? Suggest a correction